Bulgaria Pharmaceuticals and Healthcare Report Q3 2008 Provides Independent Forecasts on Bulgaria's Pharmaceuticals and Healthcare Industry.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/55c274/bulgaria_pharmaceu) has announced the addition of the "Bulgaria Pharmaceuticals and Healthcare Report Q3 2008" report to their offering. BMI's Bulgaria Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Bulgaria's pharmaceuticals and healthcare industry. BMI's revised Business Environment Rankings for Q308 once again finds Bulgaria in the joint second position, alongside the Czech Republic Czech Republic, Czech Česká Republika (2005 est. pop. 10,241,000), republic, 29,677 sq mi (78,864 sq km), central Europe. It is bordered by Slovakia on the east, Austria on the south, Germany on the west, and Poland on the north. , but this time also alongside Latvia, out of the 17 regional markets surveyed in CEE cee n. The letter c. . Bulgaria's recently attained EU membership and a favourable business climate have resulted in the improvement in the country's longer term pharmaceutical market outlook, which is already being recognised by foreign firms. Large European companies It may never be fully completed or, depending on its its nature, it may be that it can never be completed. However, new and revised entries in the list are always welcome. This is a list of companies from the countries in the European Union. are already active in the market, having acquired shares in local players, which are mainly engaged in the production of generic medicines. Generic drugs presently account for over a quarter of the market by value and will continue to gain shares at the expense of the costlier, patented variety. In the first three months of 2008, Actavis Bulgaria launched a number of new generics, including cardiovascular agents fosinopril and lisinopril, oncology drugs irinotecan (generic version of Pfizer's Camptosar) and bicalutamide, and antidepressant antidepressant, any of a wide range of drugs used to treat psychic depression. They are given to elevate mood, counter suicidal thoughts, and increase the effectiveness of psychotherapy. sertraline sertraline /ser·tra·line/ (ser´trah-len) a selective serotonin reuptake inhibitor used as the hydrochloride salt in the treatment of depression, obsessive-compulsive disorder, and panic disorder. (generic version of Pfizer's Zoloft). Domestic companies are also using their clout to expand regionally. To this end, in March 2008, Bulgarian drugmaker Sopharma announced that it is planning a regional expansion, as it attempts to bolster its bottom line. To facilitate the move, Sopharma has formed a joint venture with Polish Natur Produkt Zdrovit and is also on the verge On the Verge (or The Geography of Yearning) is a play written by Eric Overmyer. It makes extensive use of esoteric language and pop culture references from the late nineteenth century to 1955. of buying a pharmaceutical plant in Serbia. However, chronic funding shortages plaguing the healthcare sector will continue to hamper the government's attempt to modernise and improve services. Nevertheless, the new Health Minister appointed following a recent cabinet reshuffle - is committed to allocating around 5% of GDP GDP (guanosine diphosphate): see guanine. is needed for healthcare. The Minister was quick to emphasise the importance of developing a national healthcare strategy and the fact that serious structural changes would be implemented throughout every level of the system. In fact, the government is already planning to liberalise Verb 1. liberalise - become more liberal; "The laws liberalized after Prohibition" liberalize change - undergo a change; become different in essence; losing one's or its original nature; "She changed completely as she grew older"; "The weather changed last the health insurance sector in the hope that private sector involvement would increase efficiency and introduce competition, bringing down the cost of premiums. The cabinet is thought to be considering ending the monopoly of the NHIF NHIF National Health Insurance Fund (various countries) , with a number of models proposed. The result could be that the NHIF would be the only distributor for basic health care packages, while private insurers would compete for the remaining coverage. While the changes have the potential to bolster the growth of the pharmaceutical market, forecasts - which have recently been revised upwards after the new IMS Health IMS Health (NYSE: RX) is an international consulting and data services company that supplies the pharmaceutical industry with sales data and consulting services. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. figures were released - will continue to reflect improved opportunities for manufacturers of long-term and chronic treatments, an increase in foreign direct investment (FDI FDI See: Foreign direct investment ) and the introduction of higher-quality and thus more expensive products as replacements for medicines not compliant with EU standards. Key Topics Covered: - Executive Summary - Bulgaria Pharmaceuticals And Healthcare SWOT - Bulgaria Political SWOT - Bulgaria Economic SWOT - Bulgaria Business Environment SWOT - Pharmaceutical Business Environment Ratings - Table: Central and Eastern Europe The term "Central and Eastern Europe" came into wide spread use, replacing "Eastern bloc", to describe former Communist countries in Europe, after the collapse of the Iron Curtain in 1989/90. Business Environment Rating - Limits Of Potential Returns - Risks To Realisation Of Returns - Bulgaria - Market Summary - Regulatory Regime - Recent Regulatory Developments - Intellectual Property Environment - Intellectual Property Deficiencies - Corruption And Counterfeit Drugs - Pricing Regime - Tables Companies Mentioned: - GlaxoSmithKline - Novartis - Sanofi-Aventis - Pfizer - Merck & Co - Actavis Bulgaria (formerly Balkanpharma) - Sopharma - Biovet For more information visit http://www.researchandmarkets.com/research/55c274/bulgaria_pharmaceu |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion